Mission Therapeutics
Pre-clinicalDeubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Founded
2011
Focus
Small Molecules
About
Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Funding History
3Total raised: $174M
Series C$68MPfizer Venture InvestmentsJul 15, 2021
Series B$86MNovo HoldingsJun 15, 2018
Series A$20MSR OneJan 15, 2015
Company Info
TypePrivate
Founded2011
LocationCambridge, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile